Organization
AusperBio Therapeutics
1 clinical trial
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AHB-137 With Single Ascending Doses and Multiple Doses in Healthy Volunteers and Initial Efficacy in Chronic Hepatitis B PatientsStatus: Active (not recruiting), Estimated PCD: 2024-08-31